IL1B and osteoarthritis: Studies have shown that levels of inflammatory mediators, such as IL-6, IL-1β, COX-2, and PGE2, undergo significant changes throughout the progression of OA (4); therefore, attenuating IL-1β-induced inflammation in chondrocytes may offer a potential treatment strategy for osteoarthritis.